✦ LIBER ✦

Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis

✍ Scribed by Giovannoni, Gavin; Radue, Ernst-Wilhelm; Havrdova, Eva; Riester, Katherine; Greenberg, Steven; Mehta, Lahar; Elkins, Jacob

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Daclizumab high-yield process in relapsi

✍ Giovannoni, Gavin; Gold, Ralf; Selmaj, Krzysztof; Havrdova, Eva; Montalban, Xavi 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 334 KB

Daclizumab high-yield process in relapsi

✍ Gold, Ralf; Giovannoni, Gavin; Selmaj, Krzysztof; Havrdova, Eva; Montalban, Xavi 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 416 KB

Managing side effects of interferon-beta

✍ Frederick E. Munschauer III; Revere Philip Kinkel 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 808 KB

Secretory Phospholipase A2 activity in s

✍ Siroos, Bahaadin; Balood, Mohammad; Zahednasab, Hamid; Mesbah-Namin, Seyed Alire 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Effect of natalizumab on clinical and ra

✍ Melin, A.; Outteryck, O.; Collongues, N.; Zéphir, H.; Fleury, M. C.; Blanc, F.; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 305 KB

P02-388 - Positive effect of escitalopra

✍ Mitsonis, C.; Zervas, I.; Potagas, C.; Dimopoulos, N.; Psara, V.; Gkeka, A.E.; P 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 28 KB